US Patent Issued to Medicrinia on April 7 for "Composition comprising hyaluronic acid and pluronic for preventing or treating articular and cartilage injury" (South Korean Inventor)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,297, issued on April 7, was assigned to Medicrinia Co. Ltd. (Seoul, South Korea).

"Composition comprising hyaluronic acid and pluronic for preventing or treating articular and cartilage injury" was invented by Yoo Jin Ha (Jeju-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a hydrogel composition prepared without using a binder. The composition is easy to inject into the human body and has a therapeutic effect on intraarticular lesions and inflammation. The hydrogel of the present invention, which is prepared without a binder, is degraded in an articulation for a long time due to the increased viscoela...